To include your compound in the COVID-19 Resource Center, submit it here.

Ascendis and Catalent price follow-ons

Catalent Inc. (NYSE:CTLT) and Ascendis Pharma A/S (NASDAQ:ASND) each priced follow-on offerings, raising more than $380 million.

Ascendis raised $134.9 million on Sept. 27 through the sale of 3.8 million

Read the full 293 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE